N-α,N-ω-,N-ω′-Tri-Z-D-arginine

N-α,N-ω-,N-ω′-Tri-Z-D-arginine is a protected D-arginine derivative in which the α-amino group and the two guanidinium-forming nitrogens associated with the ω and ω′ positions are masked as Z (benzyloxycarbonyl) carbamates. The molecule retains the D-configured stereocenter of the arginine backbone and presents a side chain that is chemically stabilized against premature guanidinium reactivity during peptide coupling. Benzyl-based Z protecting groups provide controlled deprotection behavior under hydrogenolysis or strong base/acid conditions depending on the downstream strategy, while the ester-free, fully carbamate-protected architecture reduces undesired salt formation and side reactions. The protected guanidine functionality and the N-protected α-amino group make the compound suitable as a chiral amino acid building block for sequential assembly and for generating arginine-containing peptide analogs with defined chemoselectivity.

1. Peptide Synthesis

N-α,N-ω-,N-ω′-Tri-Z-D-arginine is applied in peptide synthesis as a D-arginine peptide building block where Z-protected α-amino and masked guanidine nitrogens suppress side reactions such as guanidinium acylation or base-promoted rearrangements during coupling. The presence of three carbamate-protected nitrogens supports stepwise N-terminal activation and amide bond formation while maintaining the guanidine functionality in a protected, non-nucleophilic state. Deprotection after chain assembly can regenerate the arginine guanidinium for salt-bridge formation and electrostatic recognition in the final peptide. Downstream peptide analog preparation can therefore proceed with controlled stereochemical fidelity, enabling incorporation of D-arginine residues into structured sequences for biochemical research and materials-oriented peptide design.

2. Bioconjugation Chemistry

N-α,N-ω-,N-ω′-Tri-Z-D-arginine is suitable for bioconjugation workflows that require arginine-rich linkers or guanidinium-bearing handles generated after selective deprotection. The protected guanidine nitrogens reduce uncontrolled binding and nonspecific interactions during conjugation chemistry, while the D-configuration can be used to tune protease stability of the resulting conjugate. Z carbamate masking allows the compound to be handled as a defined chiral intermediate for constructing peptide-based targeting motifs, affinity tags, or cell-penetrating segment precursors. Regeneration of the guanidinium group after coupling can enable strong ionic interactions with anionic biomolecules, supporting downstream formation of labeled conjugates and functional biomolecule scaffolds.

3. Protected Amino Acid Synthesis

N-α,N-ω-,N-ω′-Tri-Z-D-arginine is used as a protected amino acid intermediate in synthetic organic chemistry where multi-nitrogen protection is required to achieve chemoselective transformations. Z protection at the α-amino and ω/ω′ guanidinium-related nitrogens stabilizes the highly basic arginine side chain, reducing salt formation and improving compatibility with peptide coupling reagents and purification conditions. The defined D stereochemistry makes the compound applicable to stereocontrolled derivatization routes that preserve chiral integrity from intermediate to final peptide or peptidomimetic. Downstream processing can include conversion into activated derivatives for sequential assembly, or controlled deprotection to expose guanidinium for further functional group installation.

4. Peptidomimetics And SAR Studies

N-α,N-ω-,N-ω′-Tri-Z-D-arginine is applied in peptidomimetic construction and structure-activity relationship studies where arginine side-chain charge density and stereochemistry are key determinants of molecular recognition. Z-protected guanidine nitrogens enable incorporation into analog libraries without premature side-chain participation, allowing consistent synthesis of arginine-containing variants for comparative evaluation. D-arginine incorporation can be used to probe stereochemical effects on binding modes and conformational preferences in peptide-like scaffolds. After assembly, guanidinium deprotection yields functional arginine residues that can participate in hydrogen bonding and electrostatic interactions, supporting generation of SAR-focused analogs and mechanistic probes.

5. Pharmaceutical Intermediate Preparation

N-α,N-ω-,N-ω′-Tri-Z-D-arginine serves as a manufacturing-relevant chiral intermediate for producing arginine-containing peptide intermediates used in process chemistry and fine chemical synthesis. The tri-Z protection pattern provides a practical route to handle a strongly basic amino acid derivative without uncontrolled reactivity, supporting reproducible coupling steps in protected amino acid chemistry. Controlled deprotection of Z groups enables downstream conversion to guanidinium-bearing intermediates that can be further elaborated into peptide fragments, peptidomimetic building blocks, or formulation-compatible charged motifs. The compound's stereodefined D-arginine backbone aligns with industrial needs for consistent chiral quality in peptide-based manufacturing streams and applied synthetic methodology development.

1. Glucagonlike peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells

2. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling

3. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

4. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

5. Cationic cell-penetrating peptides are potent furin inhibitors